SCHEMBL14112152

SCHEMBL14112152

BC(=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747830 0.70
Bicarbonate SCHEMBL1260607 0.67
SCHEMBL16417859 0.67
SCHEMBL10150955 0.67
SCHEMBL57743 0.67 ACE (0.40)
SCHEMBL8225575 0.67
SCHEMBL18462016 0.65
SCHEMBL2063233 0.63
SCHEMBL7744463 0.63
Glycolic Acid SCHEMBL1222 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118324736-A Preparation method of sugar carbene, carboglycosidic glycosyl boron compound and synthesis method thereof 南开大学 2024-07-12 CN claimed
CN-118324736-A Preparation method of sugar carbene, carboglycosidic glycosyl boron compound and synthesis method thereof 南开大学 2024-07-12 CN disclosed
US-20080160028-A1 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-ALPHA THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2008-07-03 US disclosed